Major Stock Moves
Witness Monday's rising stock futures following the S&P 500's impressive month of gains. Stay tuned as Wall Street focuses on earnings from tech giants Apple and Amazon.com, along with the highly anticipated monthly U.S. jobs r...
Pfizer's Weight Loss Drug Halted
Pfizer Inc. shares fell after halting the development of an oral weight loss drug due to safety concerns, causing investor worry about a competing therapy. The decision was based on elevated levels of liver enzymes f...
Trading at the beginning of the week
US stock indices are showing a slight decline at the start of trading on Monday after a strong rise on Friday and all of last week's results.
The Dow Jones Industrial Average index was down 5.52 points (0.02%) a...
Trading opened
Key indices on the New York Stock Exchange on Tuesday morning are changing in different directions.
The Dow Jones Industrial Average rose 105.50 points (0.30%) to 35,027.38 in the first minutes of trading.
The S&P 500 index gain...
US stock indices on Tuesday
The S&P 500 and Nasdaq Composite oscillated between losses and gains, while the Dow Jones Industrial Average jumped, led by Amgen, after the biotech giant announced a $6 billion share buyback.
In news of the shakeout...
Vaccine for children
Pfizer and BioNTech have urged US authorities to approve a coronavirus vaccine for children aged 6 months to 5 years, according to a statement published on Pfizer's website on Tuesday.
Pfizer's Albert Bourla said...
Stock indices on Tuesday
US stock indices will open lower, which could be another volatile session for investors after Monday's strong swings. Nasdaq Composite futures are down 2%, while S&P 500 and Dow Jones futures are down about 0.7%.
On Tue...
Vaccination against COVID
Albert Bourla, CEO of the US pharmaceutical company Pfizer, believes it is necessary to vaccinate people with three doses of the coronavirus vaccine to fight the pandemic&nb...
Omicron vaccine
U.S. company Pfizer said that a vaccine that is adapted to the omicron strain of coronavirus will be ready in March 2022. Pfizer CEO Albert Bourla announced this on Monday.
"This vaccine ...
Market analysts and Pfizer stock
Pfizer's (PFE) share price could hit a new high in the coming days as the US FDA is expected to receive approval for its COVID pills as early as today. Market analysts are raising their forecasts for Pfizer shares on...
Buying for cash
Arena Pharmaceuticals (ARNA) shares rose 93% in premarket trading on Monday after Pfizer (PFE) announced a $6.7bn cash acquisition at $100 a share double the current price. Market analysts are raisi...
Omicron not a threat to the economy
US stock futures are set for a third day of gains as investors bet that the new variant of the COVID-19 virus will not pose a major threat to the economy.
Major futures indices are anticipating a 0.3% rise at the...
New strain and the economy
US stock indices fell before the opening of trading on Tuesday after Fed Chairman Jerome Powell said risks to the economy, the labour market and inflation could become more difficult with...
Fighting a new strain
The stock market recovered slightly at the premarket on Monday after a sharp fall on Friday when the World Health Organisation (WHO) said that the new COVID-19 strain first identified in South Africa was a "strain of concern".
...
Booster vaccines
The FDA and CDC in the US on Friday approved Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) booster vaccines against COVID-19 for all adults in the US. Revaccination with J&...
Government contract for Pfizer
Shares in Pfizer (PFE) have risen amid reports that the US government has ordered 10 million courses of treatment with its Pfizer Paxlovid tablets for COVID-19.
President Joe Biden said o...
Split into two companies
Johnson & Johnson's (JNJ) share price rose on the premarket on Friday after the company announced its intention to spin off its healthcare business into a new publicly traded company.&n...
Shares have fallen
Moderna (MRNA) shares have lost most of their growth since the start of 2021, last week's financial report was significantly worse than market analysts' forecasts and confirmed the fears of many investors.
Moderna (MRNA)'s share ...
The COVID pill
Shares of Pfizer (PFE) jumped sharply Friday, following the release of stronger efficacy results for its COVID-19 pill compared to its Merck (MRK) counterpart. Shares of other coronavirus drug makers as well as vaccine makers fell. He...
2021 outlook
Pfizer (PFE) shares rose sharply by 4% on Tuesday after the company beat analysts' Q3 revenue and earnings estimates and raised its sales forecast for 2021. Pfizer investors are encouraged by expected sales of booster doses of COVID-19 ...
NEW YORK NEWS
News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova
Development Director
